Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 12,651 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe sold 12,651 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $16.79, for a total transaction of $212,410.29. Following the transaction, the chief financial officer now owns 211,000 shares of the company’s stock, valued at $3,542,690. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Oluyemi Okupe also recently made the following trade(s):

• On Tuesday, September 3rd, Oluyemi Okupe sold 11,609 shares of Hims & Hers Health stock. The stock was sold at an average price of $14.60, for a total transaction of $169,491.40.
• On Tuesday, June 25th, Oluyemi Okupe sold 11,546 shares of Hims & Hers Health stock. The shares were sold at an average price of $22.21, for a total transaction of $256,436.66.

Hims & Hers Health Stock Performance

Shares of NYSE:HIMS opened at $17.27 on Wednesday. The business has a fifty day moving average of $17.11 and a 200-day moving average of $17.13. Hims & Hers Health, Inc. has a twelve month low of $5.65 and a twelve month high of $25.74. The firm has a market cap of $3.71 billion, a PE ratio of -1,727.00 and a beta of 1.06.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Hims & Hers Health had a net margin of 1.70% and a return on equity of 5.25%. The firm had revenue of $315.65 million during the quarter, compared to analysts’ expectations of $302.43 million. During the same quarter last year, the company posted ($0.03) EPS. The company’s quarterly revenue was up 51.8% compared to the same quarter last year. On average, analysts anticipate that Hims & Hers Health, Inc. will post 0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Hims & Hers Health by 164.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 528,142 shares of the company’s stock valued at $10,663,000 after buying an additional 328,142 shares during the period. Cim LLC acquired a new stake in Hims & Hers Health in the second quarter worth about $1,445,000. Sanctuary Advisors LLC bought a new stake in Hims & Hers Health during the 2nd quarter worth about $415,000. Creative Planning acquired a new position in Hims & Hers Health during the 2nd quarter valued at about $443,000. Finally, Scientech Research LLC bought a new position in shares of Hims & Hers Health in the 2nd quarter valued at about $1,474,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HIMS shares. Jefferies Financial Group upped their price target on Hims & Hers Health from $14.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, June 27th. Piper Sandler restated a “neutral” rating and issued a $18.00 target price on shares of Hims & Hers Health in a research note on Tuesday, August 6th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Hims & Hers Health from $16.00 to $23.00 and gave the stock a “hold” rating in a research note on Wednesday, August 7th. Imperial Capital cut shares of Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research note on Friday, August 9th. Finally, TD Cowen lifted their target price on shares of Hims & Hers Health from $15.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, July 11th. Eight investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $19.86.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.